IBDEI1KP ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25141,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,25141,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,25142,0)
 ;;=N41.9^^107^1213^38
 ;;^UTILITY(U,$J,358.3,25142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25142,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,25142,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,25142,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,25143,0)
 ;;=N70.91^^107^1213^75
 ;;^UTILITY(U,$J,358.3,25143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25143,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,25143,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,25143,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,25144,0)
 ;;=N70.93^^107^1213^74
 ;;^UTILITY(U,$J,358.3,25144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25144,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,25144,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,25144,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,25145,0)
 ;;=N70.92^^107^1213^55
 ;;^UTILITY(U,$J,358.3,25145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25145,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,25145,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,25145,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,25146,0)
 ;;=N73.9^^107^1213^37
 ;;^UTILITY(U,$J,358.3,25146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25146,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,25146,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,25146,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,25147,0)
 ;;=A56.11^^107^1213^36
 ;;^UTILITY(U,$J,358.3,25147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25147,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,25147,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,25147,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,25148,0)
 ;;=N73.5^^107^1213^64
 ;;^UTILITY(U,$J,358.3,25148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25148,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,25148,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,25148,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,25149,0)
 ;;=N72.^^107^1213^35
 ;;^UTILITY(U,$J,358.3,25149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25149,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,25149,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,25149,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,25150,0)
 ;;=N76.3^^107^1213^92
 ;;^UTILITY(U,$J,358.3,25150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25150,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,25150,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,25150,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,25151,0)
 ;;=N76.1^^107^1213^88
 ;;^UTILITY(U,$J,358.3,25151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25151,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,25151,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,25151,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,25152,0)
 ;;=N76.2^^107^1213^91
 ;;^UTILITY(U,$J,358.3,25152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25152,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,25152,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,25152,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,25153,0)
 ;;=N76.0^^107^1213^87
 ;;^UTILITY(U,$J,358.3,25153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25153,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,25153,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,25153,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,25154,0)
 ;;=M00.20^^107^1213^3
